Dual Targeting of Soluble Oligomeric and Aggregated Transthyretin with a Monoclonal Antibody Ameliorates Experimental Neuropathy
ATTR amyloidosis comprises a spectrum of multiple clinical presentations, including, predominantly, neuropathy and cardiomyopathy. The common triggering pathogenic protein is misfolded transthyretin, a carrier protein that destabilizes misfolds and assembles into mature amyloid fibrils. The current...
Main Authors: | Michael Fassler, Sagi Tshori, Yaron Barac, Dawn E. Bowles, Clara Benaim, Jacob George |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/11/10/1509 |
Similar Items
-
MONOCLONAL ANTIBODY TARGETING BOTH SOLUBLE OLIGOMERIC AND AGGREGATED TRANSTHYRETIN AMELIORATES EXPERIMENTAL NEUROPATHY
by: Michael Fassler, et al.
Published: (2023-10-01) -
Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity
by: Ana Frangolho, et al.
Published: (2020-12-01) -
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
by: Giuseppe Vergaro, MD, PhD, et al.
Published: (2021-03-01) -
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner
by: Morie Gertz, et al.
Published: (2020-09-01) -
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)